Correlation Between Sensei Biotherapeutics and Achilles Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sensei Biotherapeutics and Achilles Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sensei Biotherapeutics and Achilles Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sensei Biotherapeutics and Achilles Therapeutics PLC, you can compare the effects of market volatilities on Sensei Biotherapeutics and Achilles Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sensei Biotherapeutics with a short position of Achilles Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sensei Biotherapeutics and Achilles Therapeutics.

Diversification Opportunities for Sensei Biotherapeutics and Achilles Therapeutics

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Sensei and Achilles is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Sensei Biotherapeutics and Achilles Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achilles Therapeutics PLC and Sensei Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sensei Biotherapeutics are associated (or correlated) with Achilles Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achilles Therapeutics PLC has no effect on the direction of Sensei Biotherapeutics i.e., Sensei Biotherapeutics and Achilles Therapeutics go up and down completely randomly.

Pair Corralation between Sensei Biotherapeutics and Achilles Therapeutics

Given the investment horizon of 90 days Sensei Biotherapeutics is expected to under-perform the Achilles Therapeutics. In addition to that, Sensei Biotherapeutics is 2.67 times more volatile than Achilles Therapeutics PLC. It trades about -0.18 of its total potential returns per unit of risk. Achilles Therapeutics PLC is currently generating about -0.11 per unit of volatility. If you would invest  116.00  in Achilles Therapeutics PLC on November 5, 2024 and sell it today you would lose (3.00) from holding Achilles Therapeutics PLC or give up 2.59% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sensei Biotherapeutics  vs.  Achilles Therapeutics PLC

 Performance 
       Timeline  
Sensei Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sensei Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Sensei Biotherapeutics is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Achilles Therapeutics PLC 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Achilles Therapeutics PLC are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical indicators, Achilles Therapeutics may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Sensei Biotherapeutics and Achilles Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sensei Biotherapeutics and Achilles Therapeutics

The main advantage of trading using opposite Sensei Biotherapeutics and Achilles Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sensei Biotherapeutics position performs unexpectedly, Achilles Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achilles Therapeutics will offset losses from the drop in Achilles Therapeutics' long position.
The idea behind Sensei Biotherapeutics and Achilles Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamental Analysis
View fundamental data based on most recent published financial statements